Skip to content

Lichtenstein Versus TAPP and TEP in Groin Hernioplasty

Comparison of Lichtenstein Versus TAPP and TEP Techniques for Inguinal Hernia Repair

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02928146
Acronym
TAPP&TEP
Enrollment
150
Registered
2016-10-10
Start date
2017-01-31
Completion date
2019-12-31
Last updated
2016-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

TAPP, TEP, Lichtenstein, syntethic mesh, hernioplasty

Brief summary

The aim of the study is to evaluate the effectiveness of various methods of inguinal hernia repair and to evaluate techniques of synthetic mesh fixation during laparoscopic and open hernia repair.

Detailed description

In modern literature there is no conclusive evidence for the superiority of endoscopic over open inguinal hernia repair techniques, due to the lack of prospective, multicenter, randomized studies involving a sufficient number of patients. Both Lichtenstein and TAPP/TEP techniques are widely used and accepted methods of treatment. The clinical significance of this study is to show the differences in the incidence of perioperative complications, the evaluation of postoperative pain, full recovery time and improving the quality of life. The diagnosis of inguinal hernia will be based on a physical examination performed by an experienced surgeon based on the medical history of the patient and, if necessary, on ultrasound examination of the abdominal wall. Random assignment of patients to one of three treatment arms will take place the day before the surgery using computer-generated randomization list. The operating surgeon will be determined prior to randomization. Each patient before the study will receive complete information about the study which will be explained in detail regarding all planned procedures, the patient will obtain answers to any questions. After explaining any doubts the patient will sign the informed consent to participate in the study, in the presence of the investigator. Patients will be divided into three groups - TAPP, TEP and Lichtenstein method. Patients treated by TAPP and Lichtenstein will be further divided into subgroups - fixation glue or stitching - Lichtenstein method; fixation glue, tackers or implantation without fixation - TAPP method. Patients will receive preoperative antibiotic prophylaxis with a single dose of cephalosporin. Patients undergoing surgery will be hospitalized in the Department of Surgery until the first postop day. In justified cases, hospitalization will be extended.

Interventions

PROCEDUREHernia Repair

Sponsors

Jagiellonian University
CollaboratorOTHER
Holy Jan Grande Boni Fratres Hospital in Krakow
CollaboratorUNKNOWN
Stefan Zeromski Hospital in Kraków
CollaboratorUNKNOWN
Miroslaw Szura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* male * age: 18 - 65 * planned inguinal hernia repair using synthetic implant * BMI range: 20-35 kg / m2 * written informed consent

Exclusion criteria

* prior midline laparotomy * contraindications for general anaesthesia * ASA \> IV * cirrhosis (Child B or C) or ascites * active treatment with use of chemiotherapy * incarcerated hernia

Design outcomes

Primary

MeasureTime frameDescription
Post-operative complications associated with wound30 days after surgeryWound infection with or without the need to remove the mesh, Wound necrosis, Hematoma or seroma in the wound.

Secondary

MeasureTime frame
The frequency of conversions (from laparoscopic to open approach)1 year

Other

MeasureTime frame
Evaluation of the severity of pain according to VAS (visual analogue scale)1 year after surgery
Quality of life.Prior to surgery, 1 and 6 months after the operation using SF-36 questionnaire.

Contacts

Primary ContactMiroslaw Szura, MD, PhD
msszura@gmail.com609210030
Backup ContactArtur Pasternak, MD, PhD
artur.pasternak@uj.edu.pl603642620

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026